Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011 Jun 30;364(26):2507-16 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/21639808.
Compare quality appraisals for each clinical question
- Does systemic drug therapy improve progression-free, overall survival in unresectable stage III and stage IV melanoma?